AAPL   316.73 (-0.68%)
MSFT   181.57 (-1.06%)
FB   232.20 (-1.15%)
GOOGL   1,421.37 (+0.58%)
AMZN   2,421.86 (-0.62%)
NVDA   348.71 (-3.42%)
CGC   20.01 (+3.04%)
BABA   201.72 (+1.01%)
MU   45.80 (+1.91%)
GE   6.80 (+6.08%)
TSLA   818.87 (+0.24%)
AMD   53.19 (-3.59%)
T   30.82 (+3.15%)
ACB   15.61 (-2.50%)
F   5.84 (+3.36%)
GILD   73.18 (-0.22%)
DIS   120.95 (+2.48%)
NFLX   414.77 (-3.39%)
BAC   24.28 (+7.15%)
BA   144.73 (+5.24%)
AAPL   316.73 (-0.68%)
MSFT   181.57 (-1.06%)
FB   232.20 (-1.15%)
GOOGL   1,421.37 (+0.58%)
AMZN   2,421.86 (-0.62%)
NVDA   348.71 (-3.42%)
CGC   20.01 (+3.04%)
BABA   201.72 (+1.01%)
MU   45.80 (+1.91%)
GE   6.80 (+6.08%)
TSLA   818.87 (+0.24%)
AMD   53.19 (-3.59%)
T   30.82 (+3.15%)
ACB   15.61 (-2.50%)
F   5.84 (+3.36%)
GILD   73.18 (-0.22%)
DIS   120.95 (+2.48%)
NFLX   414.77 (-3.39%)
BAC   24.28 (+7.15%)
BA   144.73 (+5.24%)
AAPL   316.73 (-0.68%)
MSFT   181.57 (-1.06%)
FB   232.20 (-1.15%)
GOOGL   1,421.37 (+0.58%)
AMZN   2,421.86 (-0.62%)
NVDA   348.71 (-3.42%)
CGC   20.01 (+3.04%)
BABA   201.72 (+1.01%)
MU   45.80 (+1.91%)
GE   6.80 (+6.08%)
TSLA   818.87 (+0.24%)
AMD   53.19 (-3.59%)
T   30.82 (+3.15%)
ACB   15.61 (-2.50%)
F   5.84 (+3.36%)
GILD   73.18 (-0.22%)
DIS   120.95 (+2.48%)
NFLX   414.77 (-3.39%)
BAC   24.28 (+7.15%)
BA   144.73 (+5.24%)
AAPL   316.73 (-0.68%)
MSFT   181.57 (-1.06%)
FB   232.20 (-1.15%)
GOOGL   1,421.37 (+0.58%)
AMZN   2,421.86 (-0.62%)
NVDA   348.71 (-3.42%)
CGC   20.01 (+3.04%)
BABA   201.72 (+1.01%)
MU   45.80 (+1.91%)
GE   6.80 (+6.08%)
TSLA   818.87 (+0.24%)
AMD   53.19 (-3.59%)
T   30.82 (+3.15%)
ACB   15.61 (-2.50%)
F   5.84 (+3.36%)
GILD   73.18 (-0.22%)
DIS   120.95 (+2.48%)
NFLX   414.77 (-3.39%)
BAC   24.28 (+7.15%)
BA   144.73 (+5.24%)
Log in

LON:EVREVRAZ Share Price, Forecast & News

GBX 278.20
+15.30 (+5.82 %)
(As of 05/26/2020 04:00 PM ET)
Add
Compare
Today's Range
266.10
Now: GBX 278.20
282.40
50-Day Range
228
MA: GBX 255.78
278
52-Week Range
200.60
Now: GBX 278.20
710.20
Volume3.70 million shs
Average Volume3.58 million shs
Market Capitalization£4.04 billion
P/E Ratio12.65
Dividend Yield34.27%
BetaN/A
EVRAZ plc, together with its subsidiaries, produces and distributes steel and related products. It operates through four segments: Steel; Steel, North America; Coal; and Other Operations. The company's products include construction products, industrial products, railway products, vanadium products, and pipes, as well as raw materials, such as iron ore, coal, and limestone products. It is involved in the extraction of vanadium ore; production of vanadium products; iron ore and coal mining and enrichment; and energy-generation, shipping, and railway transportation businesses. The company has operations in Russia, the Americas, Asia, Europe, CIS, Africa, and internationally. The company was founded in 1992 and is headquartered in Moscow, Russia. EVRAZ plc(LSE:EVR) operates independently of Lanebrook Limited as of September 3, 2018.
Read More
EVRAZ logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.7Community Rank: 1.6Dividend Strength: 1.7Insider Behavior: 3.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.04 out of 5 stars


Industry, Sector and Symbol

Industry Steel
Sub-IndustryN/A
SectorBasic Materials
CUSIPN/A
CIKN/A
Phone+44-20-78324900

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£11.91 billion
Cash FlowGBX 103.70 per share
Book ValueGBX 115.40 per share

Profitability

Miscellaneous

Employees68,379
Outstanding Shares1,451,910,016
Market Cap£4.04 billion
Next Earnings Date8/6/2020 (Estimated)
OptionableOptionable

Receive EVR News and Ratings via Email

Sign-up to receive the latest news and ratings for EVR and its competitors with MarketBeat's FREE daily newsletter.

EVRAZ (LON:EVR) Frequently Asked Questions

How has EVRAZ's stock been impacted by COVID-19 (Coronavirus)?

EVRAZ's stock was trading at GBX 247.30 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, EVR shares have increased by 12.5% and is now trading at GBX 278.20. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of EVRAZ?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for EVRAZ in the last year. There are currently 2 sell ratings and 1 hold rating for the stock, resulting in a consensus recommendation of "Sell." View analyst ratings for EVRAZ.

When is EVRAZ's next earnings date?

EVRAZ is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for EVRAZ.

How often does EVRAZ pay dividends? What is the dividend yield for EVRAZ?

EVRAZ announced a dividend on Thursday, February 27th. Investors of record on Thursday, March 5th will be paid a dividend of GBX 0.40 per share on Friday, March 27th. This represents a dividend yield of 8.53%. The ex-dividend date is Thursday, March 5th. This is an increase from EVRAZ's previous dividend of GBX 0.35. The official announcement can be accessed at this link. View EVRAZ's dividend history.

What price target have analysts set for EVR?

3 brokers have issued twelve-month price objectives for EVRAZ's stock. Their forecasts range from GBX 300 to GBX 530. On average, they anticipate EVRAZ's share price to reach GBX 430 in the next year. This suggests a possible upside of 54.6% from the stock's current price. View analysts' price targets for EVRAZ.

Has EVRAZ been receiving favorable news coverage?

Media coverage about EVR stock has been trending somewhat negative on Tuesday, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. EVRAZ earned a news impact score of -1.9 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news aboutEVRAZ.

Who are some of EVRAZ's key competitors?

What other stocks do shareholders of EVRAZ own?

Based on aggregate information from My MarketBeat watchlists, some companies that other EVRAZ investors own include Centrica (CNA), KAZ Minerals (KAZ), British Land (BLND), easyJet (EZJ), Glencore (GLEN), Standard Chartered (STAN), Anglo American (AAL), BP (BP), Gulf Keystone Petroleum (GKP) and GlaxoSmithKline (GSK).

Who are EVRAZ's key executives?

EVRAZ's management team includes the following people:
  • Mr. Alexander Vladimirovich Frolov, CEO & Director (Age 55)
  • Mr. Nikolay Ivanov, Chief Financial Officer (Age 47)
  • Ms. Irina Bakhturina, Director of Investor Relations
  • Mr. Sergei Vasiliev, VP of Compliance with Bus. Procedures & Asset Protection (Age 52)
  • Ms. Yanina Stanulenaite, VP of Legal (Age 39)

What is EVRAZ's stock symbol?

EVRAZ trades on the London Stock Exchange (LON) under the ticker symbol "EVR."

How do I buy shares of EVRAZ?

Shares of EVR and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is EVRAZ's stock price today?

One share of EVR stock can currently be purchased for approximately GBX 278.20.

How big of a company is EVRAZ?

EVRAZ has a market capitalization of £4.04 billion and generates £11.91 billion in revenue each year. EVRAZ employs 68,379 workers across the globe.

What is EVRAZ's official website?

The official website for EVRAZ is www.evraz.com.

How can I contact EVRAZ?

EVRAZ's mailing address is 5th Fl, 6 St. Andrew Street, LONDON, EC4A 3AE, United Kingdom. The company can be reached via phone at +44-20-78324900.

This page was last updated on 5/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.